303 related articles for article (PubMed ID: 21415022)
21. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
22. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
[TBL] [Abstract][Full Text] [Related]
23. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Lu LY; Lam HC; Tsai KW; Huang WC; Shiue YL
Clin Exp Rheumatol; 2018; 36(3):471-478. PubMed ID: 29303707
[TBL] [Abstract][Full Text] [Related]
24. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
Wang JL; Yin WJ; Zhou LY; Zhou G; Liu K; Hu C; Zuo XC; Wang YF
Clin Rheumatol; 2020 Mar; 39(3):769-778. PubMed ID: 31823140
[TBL] [Abstract][Full Text] [Related]
25. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.
Demers AA; Nugent Z; Mihalcioiu C; Wiseman MC; Kliewer EV
J Am Acad Dermatol; 2005 Aug; 53(2):320-8. PubMed ID: 16021129
[TBL] [Abstract][Full Text] [Related]
26. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of nonmelanoma skin cancer.
Strom SS; Yamamura Y
Clin Plast Surg; 1997 Oct; 24(4):627-36. PubMed ID: 9342506
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.
Al-Aly Z; Pan H; Zeringue A; Xian H; McDonald JR; El-Achkar TM; Eisen S
Transl Res; 2011 Jan; 157(1):10-8. PubMed ID: 21146146
[TBL] [Abstract][Full Text] [Related]
29. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
[TBL] [Abstract][Full Text] [Related]
30. No end in sight: the skin cancer epidemic continues.
Donaldson MR; Coldiron BM
Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
[TBL] [Abstract][Full Text] [Related]
31. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
32. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
33. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
34. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
Chung CP; Rohan P; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
[TBL] [Abstract][Full Text] [Related]
36. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
Troyanova P; Danon S; Ivanova T
Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
38. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
Plesko I; Severi G; Obsitníková A; Boyle P
Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
[TBL] [Abstract][Full Text] [Related]
39. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
40. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
